MedPath

Renal Allograft : Evaluation of Parenchymal Fibrosis by Elastography

Not Applicable
Conditions
Renal Transplant
Interventions
Device: Magnetic Resonance Elastography, and Supersonic Shear Imaging
Registration Number
NCT01234363
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

The purpose of this study is to assess the potential of elastography for noninvasive assessment of fibrosis in renal allograft.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Renal allograft performed less than 3 months before enrolment
Exclusion Criteria
  • Contra-indication to magnetic resonance imaging
  • Contra-indication to biopsy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Magnetic Resonance Elastography, Supersonic Shear ImagingMagnetic Resonance Elastography, and Supersonic Shear ImagingMagnetic Resonance Elastography and Supersonic Shear Imaging
Primary Outcome Measures
NameTimeMethod
Correlation between elasticity (as measured by elastography) and (a) Banff score for fibrosis, (b) glomerular filtration rate assessed by creatinine clearance, (c) glomerular filtration rate assessed by insulin clearance3 months and 12 months after graft
Secondary Outcome Measures
NameTimeMethod
Correlation between elasticity and arterial resistance index3 months and 12 months after graft
Number of technical failures12 months
Tolerance (assessed by a questionnaire)3 months and 12 months after graft
Evolution of the elasticity of the transplant between 3 and 12 months after graft3 months and 12 months after graft

Trial Locations

Locations (1)

Service de Radiologie, Pavillon P Radio, Hôpital Edouard Herriot

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath